DUBLIN, Ohio — Longtime Cardinal Health board member John B. McCoy is stepping down and will be replaced by Bruce L. Downey, former chief executive officer of Barr Pharmaceuticals and previous chairman of the Generic Pharmaceutical Association.
Downey is also chairman of the Board of Ambassadors for Johns Hopkins’ Project RESTORE, which funds research and clinical trials for treatments for multiple sclerosis and transverse myelitis, a neurological disorder in the spinal cord. He is also sits on the board of Momenta Pharmaceuticals and in April became a partner in the venture firm NewSpring Capital’s second health fund.
McCoy has served on the Cardinal board of directors for 22 years. He is leaving for personal reasons, according to a press release. He will leave after Cardinal completes its spinoff of CareFusion.
No comments:
Post a Comment